Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 2/2007

01-04-2007 | ORIGINAL ARTICLE

Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy

Authors: Yohei Horikawa, Teruaki Kumazawa, Shintaro Narita, Takamitsu Inoue, Takeshi Yuasa, Shinobu Matsuura, Hiroshi Nanjo, Shigeru Satoh, Norihiko Tsuchiya, Tomonori Habuchi

Published in: International Journal of Clinical Oncology | Issue 2/2007

Login to get access
Metadata
Title
Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy
Authors
Yohei Horikawa
Teruaki Kumazawa
Shintaro Narita
Takamitsu Inoue
Takeshi Yuasa
Shinobu Matsuura
Hiroshi Nanjo
Shigeru Satoh
Norihiko Tsuchiya
Tomonori Habuchi
Publication date
01-04-2007
Publisher
Springer-Verlag
Published in
International Journal of Clinical Oncology / Issue 2/2007
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-006-0637-7

Other articles of this Issue 2/2007

International Journal of Clinical Oncology 2/2007 Go to the issue

INTRODUCTION TO REVIEW ARTICLES

Recent developments and perspectives of image-guided precision surgery for malignancies

REVIEW ARTICLE

MRI-guided laparoscopic and robotic surgery for malignancies

REVIEW ARTICLE

CT-guided radiofrequency ablation for lung cancer

CASE REPORT

Paraneoplastic vasculitis of central nervous system presenting as recurrent cryptogenic stroke

CASE REPORT

Malignant paraganglioma arising from the kidney

ORIGINAL ARTICLE

A review of 331 rhabdomyosarcoma cases in patients treated between 1991 and 2002 in Japan
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits